Abstract
The presence of hepatitis B virus (HBV) proteins leads to changes in the cellular gene expression. As a consequence, the cellular signaling processes are influenced by the actions of HBV proteins. It has been shown that HBV nucleocapsid protein and the amino-terminal part of polymerase termed as terminal protein (TP) could inhibit interferon signaling. Further, the global gene expression profiles differ in hepatoma cells with and without HBV gene expression and replication. The expression of interferon (IFN) stimulated genes (ISGs) was differently regulated in cells with HBV replication and could be modulated by antiviral treatments. The HBV TP has been found to modulate the ISG expression and enhance the HBV replication. The modulation of the cellular signaling processes by HBV may have significant implications for pathogenesis.
Similar content being viewed by others
References
Bouchard M J, Schneider R J. 2004. The enigmatic X gene of hepatitis B virus. J Virol, 78: 12725–12734.
Christen V, Duong F, Bernsmeier C, et al. 2007. Inhibition of alpha interferon signaling by hepatitis B virus. J Virol, 81(1): 159–165.
Dienes H P, Hess G, Wöorsdörfer M, et al. 1991. Ultrastructural localization of interferon-producing cells in the livers of patients with chronic hepatitis B. Hepatology, 13(2): 321–326.
Duong F H, Christen V, Berke J M, et al. 2005. Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1. J Virol, 79(24): 15342–15350.
Duong F H, Filipowicz M, Tripodi M, et al. 2004. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology, 126(1): 263–277.
Fang J W, Wu P C, Lai C L, et al. 1994. Hepatic expression of interferon-alpha in chronic hepatitis B virus infection. Dig Dis Sci, 39(9): 2014–2021.
Fern’andez M, Quiroga J A, Carreño V. 2003. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol, 84(Pt 8): 2073–2082.
Foster G R, Ackrill A M, Goldin R D, et al. 1991. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci USA, 88(7): 2888–2892. Erratum in: Proc Natl Acad Sci USA, 92 (8): 3632.
Foster G R, Goldin R D, Hay A, et al. 1993. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy. Hepatology, 17(5): 757–762.
Ganem D, Pollack J R, Tavis J. 1994. Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect Agents Dis, 3: 85–93.
Gordien E, Rosmorduc O, Peltekian C, et al. 2001. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol, 75(6): 2684–2691.
Guan S H, Lu M, Grünewald P, et al. 2007. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroenterol, 13(2): 228–235.
Guo Y, Guo H, Zhang L, et al. 2005. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol, 79(22): 14392–14403.
Haller O, Stertz S, Kochs G. 2007. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect, 9: 1636–1643.
Janssen H L, van Zonneveld M, Senturk H, et al. 2005. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet, 365: 123–129.
Jilbert A R, Burrell C J, Gowans E J, et al. 1986. Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue. Hepatology, 6(5): 957–961.
Lau G K, Piratvisuth T, Luo K X, et al. 2005. Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med, 352: 2682–2695.
Locarnini S, Shaw T, Dean J, et al. 2005. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol, 32(2): 113–121.
Nouri-Aria K T, Arnold J, Davison F, et al. 1991. Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. Hepatology, 13(6): 1029–1034. Erratum in: Hepatology, 14 (6): 1308.
Nakanishi F, Ohkawa K, Ishida H, et al. 2005. Alteration in gene expression profile by full-length hepatitis B virus genome. Intervirology, 48(2–3): 77–83.
Rang A, Bruns M, Heise T, Will H. 2002. Antiviral activity of interferon-alpha against hepatitis B virus can be studied in non-hepatic cells and Is independent of MxA. J Biol Chem, 277(10): 7645–7647.
Rosmorduc O, Sirma H, Soussan P, et al. 1999. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. J Gen Virol, 80(Pt 5): 1253–1262.
Twu J S, Lee C H, Lin P M, et al. 1988. Hepatitis B virus suppresses expression of human beta-interferon. Proc Natl Acad Sci USA, 85(1): 252–256.
Twu J S, Schloemer R H. 1989. Transcription of the human beta interferon gene is inhibited by hepatitis B virus. J Virol, 63(7): 3065–3071.
Wang G H, Seeger C. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell, 71(4): 663–670.
Wang G H, Seeger C. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol, 67(11): 6507–6512.
Wang X, Yuan Z H, Zheng L J, et al. 2004. Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-alpha. World J Gastroenterol, 10(12): 1740–1745.
Whitten T M, Quets A T, Schloemer R H. 1991. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol, 65(9): 4699–4704.
Wu M, Xu Y, Lin S, et al. 2007. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J Gen Virol, 88(Pt 12): 3260–3269.
Yang J, Bo X C, Yao J, et al. 2005. Differentially expressed cellular genes following HBV: potential targets of anti-HBV drugs? J Viral Hepat, 12(4): 357–363.
Author information
Authors and Affiliations
Corresponding author
Additional information
Foundation items: Deutsche Forschungsgemeinschaft (Lu 669/2-1, GRK1045/1, and Lu 669/5-1); Joint program of Deutscher Akademischer Austauschdienst and Chinese Academy of Science.
Rights and permissions
About this article
Cite this article
Xu, Y., She, Cw., Zhang, Xy. et al. Interference of hepatitis B virus with cellular signaling. Virol. Sin. 23, 100–106 (2008). https://doi.org/10.1007/s12250-008-2940-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-008-2940-0